6 | | - | ONCERNING PROHIBITING CERTAIN PRACTICES BY ENTITIES OBLIGATED TO |
---|
7 | | - | PAY FOR PRESCRIPTION DRUG BENEFITS |
---|
8 | | - | , AND, IN CONNECTION |
---|
9 | | - | THEREWITH |
---|
10 | | - | , MAKING AN APPROPRIATION. |
---|
| 14 | + | ONCERNING PROHIBITING CERT AIN PRACTICES BY ENTITIES101 |
---|
| 15 | + | OBLIGATED TO PAY FOR PRESCRIPTION DRUG |
---|
| 16 | + | BENEFITS, AND, IN102 |
---|
| 17 | + | CONNECTION THEREWITH , MAKING AN APPROPRIATION .103 |
---|
| 18 | + | Bill Summary |
---|
| 19 | + | (Note: This summary applies to this bill as introduced and does |
---|
| 20 | + | not reflect any amendments that may be subsequently adopted. If this bill |
---|
| 21 | + | passes third reading in the house of introduction, a bill summary that |
---|
| 22 | + | applies to the reengrossed version of this bill will be available at |
---|
| 23 | + | http://leg.colorado.gov |
---|
| 24 | + | .) |
---|
| 25 | + | For contracts between a pharmacy benefit manager (PBM) and a |
---|
| 26 | + | pharmacy entered into or renewed on or after January 1, 2023, section 1 |
---|
| 27 | + | of the bill prohibits the PBM or its representative from reimbursing a |
---|
| 28 | + | pharmacy for a prescription drug in an amount less than the national |
---|
| 29 | + | average drug acquisition cost for the prescription drug. |
---|
| 30 | + | SENATE |
---|
| 31 | + | 3rd Reading Unamended |
---|
| 32 | + | May 9, 2022 |
---|
| 33 | + | SENATE |
---|
| 34 | + | Amended 2nd Reading |
---|
| 35 | + | May 6, 2022 |
---|
| 36 | + | HOUSE |
---|
| 37 | + | 3rd Reading Unamended |
---|
| 38 | + | April 22, 2022 |
---|
| 39 | + | HOUSE |
---|
| 40 | + | Amended 2nd Reading |
---|
| 41 | + | April 19, 2022 |
---|
| 42 | + | HOUSE SPONSORSHIP |
---|
| 43 | + | Will and Lindsay, Lontine, Bernett, Esgar, Jodeh, Kipp, Ricks, Weissman |
---|
| 44 | + | SENATE SPONSORSHIP |
---|
| 45 | + | Jaquez Lewis, Moreno |
---|
| 46 | + | Shading denotes HOUSE amendment. Double underlining denotes SENATE amendment. |
---|
| 47 | + | Capital letters or bold & italic numbers indicate new material to be added to existing statute. |
---|
| 48 | + | Dashes through the words indicate deletions from existing statute. Section 2 enacts the "Colorado 340B Prescription Drug Program |
---|
| 49 | + | Anti-discrimination Act" (act), which prohibits health insurers, PBMs, |
---|
| 50 | + | and other third-party payers (third-party payers) from discriminating |
---|
| 51 | + | against entities, including pharmacies, participating in the federal 340B |
---|
| 52 | + | drug pricing program (340B covered entity). Specifically, the bill |
---|
| 53 | + | prohibits a third-party payer from: |
---|
| 54 | + | ! Refusing to reimburse a 340B covered entity for dispensing |
---|
| 55 | + | 340B drugs, imposing additional requirements or |
---|
| 56 | + | restrictions on 340B covered entities, or reimbursing a |
---|
| 57 | + | 340B covered entity for a 340B drug at a rate lower than |
---|
| 58 | + | the amount paid for the same drug to pharmacies that are |
---|
| 59 | + | not 340B covered entities; |
---|
| 60 | + | ! Assessing a fee, charge back, or other adjustment against |
---|
| 61 | + | a 340B covered entity, or restricting a 340B covered |
---|
| 62 | + | entity's access to the third-party payer's pharmacy network, |
---|
| 63 | + | because the covered entity participates in the 340B drug |
---|
| 64 | + | pricing program; |
---|
| 65 | + | ! Requiring a 340B covered entity to contract with a specific |
---|
| 66 | + | pharmacy or health coverage plan in order to access the |
---|
| 67 | + | third-party payer's pharmacy network; |
---|
| 68 | + | ! Imposing a restriction or an additional charge on a patient |
---|
| 69 | + | who obtains a prescription drug from a 340B covered |
---|
| 70 | + | entity; or |
---|
| 71 | + | ! Restricting the methods by which a 340B covered entity |
---|
| 72 | + | may dispense or deliver 340B drugs. |
---|
| 73 | + | Section 2 makes a violation of the act an unfair or deceptive act or |
---|
| 74 | + | practice in the business of insurance and authorizes the commissioner of |
---|
| 75 | + | insurance to adopt rules to implement the act. |
---|
| 76 | + | Be it enacted by the General Assembly of the State of Colorado:1 |
---|
19 | | - | HE SHORT TITLE OF THIS PART 15 IS THE |
---|
20 | | - | "COLORADO 340B PRESCRIPTION DRUG PROGRAM ANTI-DISCRIMINATION |
---|
21 | | - | ACT". |
---|
22 | | - | NOTE: This bill has been prepared for the signatures of the appropriate legislative |
---|
23 | | - | officers and the Governor. To determine whether the Governor has signed the bill |
---|
24 | | - | or taken other action on it, please consult the legislative status sheet, the legislative |
---|
25 | | - | history, or the Session Laws. |
---|
26 | | - | ________ |
---|
27 | | - | Capital letters or bold & italic numbers indicate new material added to existing law; dashes |
---|
28 | | - | through words or numbers indicate deletions from existing law and such material is not part of |
---|
29 | | - | the act. 10-16-1502. Legislative declaration. (1) T HE GENERAL ASSEMBLY |
---|
30 | | - | DECLARES THAT THE PURPOSE OF THIS PART |
---|
31 | | - | 15 IS TO: |
---|
| 85 | + | HE SHORT TITLE OF THIS PART 15 IS THE8 |
---|
| 86 | + | "C |
---|
| 87 | + | OLORADO 340B PRESCRIPTION DRUG PROGRAM ANTI-DISCRIMINATION9 |
---|
| 88 | + | 1122-2- ACT".1 |
---|
| 89 | + | 10-16-1502. Legislative declaration. (1) T |
---|
| 90 | + | HE GENERAL2 |
---|
| 91 | + | ASSEMBLY DECLARES THAT THE PURPOSE OF THIS PART 15 IS TO:3 |
---|
39 | | - | ROHIBIT A PHARMACY BENEFIT MANAGER OR CARRIER FROM |
---|
40 | | - | REQUIRING A CLAIM FOR A DRUG TO INCLUDE A MODIFIER TO INDICATE THAT |
---|
41 | | - | THE DRUG IS A |
---|
42 | | - | 340B DRUG UNLESS THE CLAIM IS FOR PAYMENT , DIRECTLY |
---|
43 | | - | OR INDIRECTLY |
---|
44 | | - | , BY THE MEDICAID PROGRAM; AND |
---|
45 | | - | (c) PROVIDE FOR POWERS AND DUTIES OF THE COMMISSIONER AND |
---|
46 | | - | THE DIVISION |
---|
47 | | - | . |
---|
| 98 | + | ROHIBIT A PHARMACY BENEFIT MANAGER OR CARRIER FROM8 |
---|
| 99 | + | REQUIRING A CLAIM FOR A DRUG TO INCLUDE A MODIFIER TO INDICATE9 |
---|
| 100 | + | THAT THE DRUG IS A 340B DRUG UNLESS THE CLAIM IS FOR PAYMENT ,10 |
---|
| 101 | + | DIRECTLY OR INDIRECTLY, BY THE MEDICAID PROGRAM; AND11 |
---|
| 102 | + | (c) P |
---|
| 103 | + | ROVIDE FOR POWERS AND DUTIES OF THE COMMISSIONER AND12 |
---|
| 104 | + | THE DIVISION.13 |
---|
88 | | - | EIMBURSEMENT FOR COVERED OUTPATIENT DRUGS , AS THAT |
---|
89 | | - | TERM IS DEFINED IN SECTION |
---|
90 | | - | 42 U.S.C. SEC. 1396r-8 (k)(2), ON A |
---|
91 | | - | FEE |
---|
92 | | - | -FOR-SERVICE BASIS UNDER THE MEDICAID PROGRAM ; OR |
---|
93 | | - | (II) ANY AMOUNTS PAID BY AN INDIVIDUAL ON THE INDIVIDUAL 'S |
---|
94 | | - | OWN BEHALF OR ON BEHALF OF ANOTHER INDIVIDUAL WITHOUT A |
---|
95 | | - | CONTRACTUAL OR LEGAL OBLIGATION TO DO SO |
---|
96 | | - | . |
---|
97 | | - | (6) "M |
---|
98 | | - | EDICAID PROGRAM" MEANS THE MEDICAL ASSISTANCE |
---|
99 | | - | PROGRAM ESTABLISHED PURSUANT TO ARTICLES |
---|
100 | | - | 4 TO 6 OF TITLE 25.5. |
---|
| 144 | + | EIMBURSEMENT FOR COVERED OUTPATIENT DRUGS , AS THAT10 |
---|
| 145 | + | TERM IS DEFINED IN SECTION 42 U.S.C. SEC. 1396r-8 (k)(2), ON A11 |
---|
| 146 | + | FEE-FOR-SERVICE BASIS UNDER THE MEDICAID PROGRAM ; OR12 |
---|
| 147 | + | (II) A |
---|
| 148 | + | NY AMOUNTS PAID BY AN INDIVIDUAL ON THE INDIVIDUAL 'S13 |
---|
| 149 | + | OWN BEHALF OR ON BEHALF OF ANOTHER INDIVIDUAL WITHOUT A14 |
---|
| 150 | + | CONTRACTUAL OR LEGAL OBLIGATION TO DO SO .15 |
---|
| 151 | + | (6) |
---|
| 152 | + | "MEDICAID PROGRAM" MEANS THE MEDICAL ASSISTANCE16 |
---|
| 153 | + | PROGRAM ESTABLISHED PURSUANT TO ARTICLES 4 TO 6 OF TITLE 25.5.17 |
---|
104 | | - | CARRIER OR PHARMACY BENEFIT MANAGER THAT PROVIDES OR |
---|
105 | | - | MANAGES DRUG COVERAGE UNDER A HEALTH COVERAGE PLAN |
---|
106 | | - | ; OR |
---|
107 | | - | (II) A SYSTEM OF HEALTH INSURANCE FOR STATE OR LOCAL |
---|
108 | | - | GOVERNMENT EMPLOYEES |
---|
109 | | - | , THEIR DEPENDENTS, AND RETIREES, INCLUDING |
---|
110 | | - | A GROUP BENEFIT PLAN |
---|
111 | | - | , AS DEFINED IN SECTION 24-50-603 (9), AND A GROUP |
---|
112 | | - | HEALTH CARE PROGRAM DESIGNED PURSUANT TO SECTION |
---|
113 | | - | 24-51-1202. |
---|
| 157 | + | CARRIER OR PHARMACY BENEFIT MANAGER THAT PROVIDES19 |
---|
| 158 | + | OR MANAGES DRUG COVERAGE UNDE R A HEALTH COVERAGE PLAN ; |
---|
| 159 | + | OR20 |
---|
| 160 | + | (II) A |
---|
| 161 | + | SYSTEM OF HEALTH INSURANCE FOR STATE OR LOCAL21 |
---|
| 162 | + | GOVERNMENT EMPLOYEES , THEIR DEPENDENTS, AND RETIREES, INCLUDING22 |
---|
| 163 | + | A GROUP BENEFIT PLAN, AS DEFINED IN SECTION 24-50-603 (9), AND A23 |
---|
| 164 | + | GROUP HEALTH CARE PROGRAM DESIGNED PURSUANT TO SECTION |
---|
| 165 | + | 24 |
---|
| 166 | + | 24-51-1202.25 |
---|
115 | | - | HIRD PARTY" DOES NOT INCLUDE: |
---|
116 | | - | (I) A |
---|
117 | | - | N INSURER THAT PROVIDES COVERAGE UNDER A POLICY OF |
---|
118 | | - | PROPERTY AND CASUALTY INSURANCE |
---|
119 | | - | ; OR |
---|
120 | | - | (II) AN INSURER OR ENTITY THAT PROVIDES HEALTH COVERAGE , |
---|
121 | | - | BENEFITS, OR COVERAGE OF PRESCRIPTION DRUGS AS PART OF COVERAGE |
---|
122 | | - | REQUIRED UNDER THE |
---|
123 | | - | "WORKERS' COMPENSATION ACT OF COLORADO", |
---|
124 | | - | ARTICLES 40 TO 47 OF TITLE 8, OR WORKERS' COMPENSATION COVERAGE |
---|
125 | | - | REQUIRED UNDER FEDERAL LAW |
---|
126 | | - | . |
---|
127 | | - | PAGE 3-HOUSE BILL 22-1122 10-16-1504. Applicability - exclusions. (1) T HIS PART 15 APPLIES |
---|
128 | | - | TO ANY THIRD PARTY THAT REIMBURSES |
---|
129 | | - | 340B COVERED ENTITIES OR |
---|
130 | | - | CONTRACT PHARMACIES IN THIS STATE |
---|
131 | | - | . |
---|
132 | | - | (2) N |
---|
133 | | - | OTHING IN THIS PART 15: |
---|
134 | | - | (a) P |
---|
135 | | - | ROHIBITS A THIRD PARTY FROM MAINTAINING DIFFERENTIAL |
---|
136 | | - | REIMBURSEMENT RATES FOR PARTICIPATING AND NONPARTICIPATING |
---|
137 | | - | PROVIDERS |
---|
138 | | - | , SO LONG AS THE RATES ARE NOT DETERMINED ON THE BASIS OF |
---|
139 | | - | A PROVIDER |
---|
140 | | - | 'S STATUS AS A 340B COVERED ENTITY OR CONTRACT |
---|
141 | | - | PHARMACY |
---|
142 | | - | ; |
---|
| 168 | + | HIRD PARTY" DOES NOT |
---|
| 169 | + | INCLUDE:26 |
---|
| 170 | + | (I) AN INSURER THAT PROVIDES COVERAGE UNDER A POLICY OF27 |
---|
| 171 | + | 1122 |
---|
| 172 | + | -4- PROPERTY AND CASUALTY INSURANCE; OR1 |
---|
| 173 | + | (II) AN INSURER OR ENTITY THAT PROVIDES HEALTH COVERAGE ,2 |
---|
| 174 | + | BENEFITS, OR COVERAGE OF PRESCRIPTION DRUGS AS PART OF COVERAGE3 |
---|
| 175 | + | REQUIRED UNDER THE "WORKERS' COMPENSATION ACT OF COLORADO",4 |
---|
| 176 | + | ARTICLES 40 TO 47 OF TITLE 8, OR WORKERS' COMPENSATION COVERAGE5 |
---|
| 177 | + | REQUIRED UNDER FEDERAL LAW .6 |
---|
| 178 | + | 10-16-1504. Applicability - exclusions. (1) THIS PART 157 |
---|
| 179 | + | APPLIES TO ANY THIRD PARTY THAT REIMBURSES 340B COVERED ENTITIES8 |
---|
| 180 | + | OR CONTRACT PHARMACIES IN THIS STATE .9 |
---|
| 181 | + | (2) NOTHING IN THIS PART 15:10 |
---|
| 182 | + | (a) PROHIBITS A THIRD PARTY FROM MAINTAINING DIFFERENTIAL11 |
---|
| 183 | + | REIMBURSEMENT RATES FOR PARTICIPATING AND NONPARTICIPATING12 |
---|
| 184 | + | PROVIDERS, SO LONG AS THE RATES ARE NOT DETERMINED ON THE BASIS13 |
---|
| 185 | + | OF A PROVIDER'S STATUS AS A 340B COVERED ENTITY OR CONTRACT14 |
---|
| 186 | + | PHARMACY;15 |
---|
| 187 | + | (b) AFFECTS A THIRD PARTY'S ABILITY TO ESTABLISH COVERAGE16 |
---|
| 188 | + | GUIDELINES AND EXCLUDE SPECIFIC DRUGS FROM ITS PRESCRIPTION DRUG17 |
---|
| 189 | + | FORMULARIES, SO LONG AS THE GUIDELINES AND EXCLUSIONS ARE NOT18 |
---|
| 190 | + | DETERMINED ON THE BASIS OF A PROVIDER'S STATUS AS A 340B COVERED19 |
---|
| 191 | + | ENTITY OR CONTRACT PHARMACY OR OF A DRUG'S STATUS AS A 340B20 |
---|
| 192 | + | DRUG; OR21 |
---|
| 193 | + | (c) REQUIRES A THIRD PARTY TO CONTRACT WITH A 340B22 |
---|
| 194 | + | COVERED ENTITY OR CONTRACT PHARMACY FOR PURPOSES OF23 |
---|
| 195 | + | PARTICIPATING IN THE THIRD PARTY'S NETWORK, SO LONG AS THE THIRD24 |
---|
| 196 | + | PARTY'S CONTRACTING DECISIONS ARE NOT DETERMINED ON THE BASIS OF25 |
---|
| 197 | + | A PROVIDER'S STATUS AS A 340B COVERED ENTITY OR CONTRACT26 |
---|
| 198 | + | PHARMACY.27 |
---|
| 199 | + | 1122 |
---|
| 200 | + | -5- 10-16-1505. Prohibition on 340B discrimination. (1) A THIRD1 |
---|
| 201 | + | PARTY THAT REIMBURSES A 340B COVERED ENTITY OR CONTRACT2 |
---|
| 202 | + | PHARMACY FOR 340B DRUGS SHALL NOT:3 |
---|
| 203 | + | (a) R |
---|
| 204 | + | EIMBURSE THE 340B COVERED ENTITY |
---|
| 205 | + | OR CONTRACT4 |
---|
| 206 | + | PHARMACY FOR A PHARMACY -DISPENSED DRUG AT A RATE LOWER THAN5 |
---|
| 207 | + | THE AMOUNT PAID FOR THE SAME DRUG TO PHARMACIES SIMILAR IN6 |
---|
| 208 | + | PRESCRIPTION VOLUME THAT ARE NOT 340B COVERED ENTITIES OR7 |
---|
| 209 | + | CONTRACT PHARMACIES ;8 |
---|
144 | | - | FFECTS A THIRD PARTY'S ABILITY TO ESTABLISH COVERAGE |
---|
145 | | - | GUIDELINES AND EXCLUDE SPECIFIC DRUGS FROM ITS PRESCRIPTION DRUG |
---|
146 | | - | FORMULARIES |
---|
147 | | - | , SO LONG AS THE GUIDELINES AND EXCLUSIONS ARE NOT |
---|
148 | | - | DETERMINED ON THE BASIS OF A PROVIDER |
---|
149 | | - | 'S STATUS AS A 340B COVERED |
---|
150 | | - | ENTITY OR CONTRACT PHARMACY OR OF A DRUG |
---|
151 | | - | 'S STATUS AS A 340B DRUG; |
---|
152 | | - | OR |
---|
153 | | - | (c) REQUIRES A THIRD PARTY TO CONTRACT WITH A 340B COVERED |
---|
154 | | - | ENTITY OR CONTRACT PHARMACY FOR PURPOSES OF PARTICIPATING IN THE |
---|
155 | | - | THIRD PARTY |
---|
156 | | - | 'S NETWORK, SO LONG AS THE THIRD PARTY'S CONTRACTING |
---|
157 | | - | DECISIONS ARE NOT DETERMINED ON THE BASIS OF A PROVIDER |
---|
158 | | - | 'S STATUS AS |
---|
159 | | - | A |
---|
160 | | - | 340B COVERED ENTITY OR CONTRACT PHARMACY . |
---|
161 | | - | 10-16-1505. Prohibition on 340B discrimination. (1) A |
---|
162 | | - | THIRD |
---|
163 | | - | PARTY THAT REIMBURSES A |
---|
164 | | - | 340B COVERED ENTITY OR CONTRACT |
---|
165 | | - | PHARMACY FOR |
---|
166 | | - | 340B DRUGS SHALL NOT: |
---|
167 | | - | (a) R |
---|
168 | | - | EIMBURSE THE 340B COVERED ENTITY OR CONTRACT |
---|
169 | | - | PHARMACY FOR A PHARMACY |
---|
170 | | - | -DISPENSED DRUG AT A RATE LOWER THAN THE |
---|
171 | | - | AMOUNT PAID FOR THE SAME DRUG TO PHARMACIES SIMILAR IN |
---|
172 | | - | PRESCRIPTION VOLUME THAT ARE NOT |
---|
173 | | - | 340B COVERED ENTITIES OR |
---|
174 | | - | CONTRACT PHARMACIES |
---|
175 | | - | ; |
---|
| 211 | + | SSESS ANY FEE, CHARGE BACK, OR OTHER ADJUSTMENT9 |
---|
| 212 | + | AGAINST THE 340B COVERED ENTITY |
---|
| 213 | + | OR CONTRACT PHARMACY ON THE10 |
---|
| 214 | + | BASIS THAT THE 340B COVERED ENTITY OR CONTRACT PHARMACY11 |
---|
| 215 | + | PARTICIPATES IN THE 340B PROGRAM;12 |
---|
| 216 | + | (c) R |
---|
| 217 | + | ESTRICT ACCESS TO THE THIRD PARTY'S PHARMACY NETWORK13 |
---|
| 218 | + | FOR ANY 340B COVERED ENTITY |
---|
| 219 | + | OR CONTRACT PHARMACY ON THE BASIS14 |
---|
| 220 | + | THAT THE 340B COVERED ENTITY OR CONTRACT PHARMACY PARTICIPATES15 |
---|
| 221 | + | IN THE 340B PROGRAM;16 |
---|
| 222 | + | (d) R |
---|
| 223 | + | EQUIRE THE 340B COVERED ENTITY |
---|
| 224 | + | OR CONTRACT17 |
---|
| 225 | + | PHARMACY TO ENTER INTO A CONTRACT WITH A SPECIFIC PHARMACY OR18 |
---|
| 226 | + | HEALTH COVERAGE PLAN TO PARTICIPATE IN THE THIRD PARTY 'S19 |
---|
| 227 | + | PHARMACY NETWORK ;20 |
---|
| 228 | + | (e) C |
---|
| 229 | + | REATE A RESTRICTION OR AN ADDITIONAL CHARGE ON A21 |
---|
| 230 | + | PATIENT WHO CHOOSES TO RECEIVE DRUGS FROM A 340B COVERED ENTITY22 OR CONTRACT PHARMACY ; 23 |
---|
| 231 | + | (f) R |
---|
| 232 | + | ESTRICT THE METHODS BY WHICH A 340B COVERED ENTITY24OR CONTRACT PHARMACY MAY DISPENSE OR DELIVER 340B DRUGS;25 |
---|
| 233 | + | (g) R |
---|
| 234 | + | EFUSE TO PROVIDE REIMBURSEMENT OR COVERAGE FOR 340B26 |
---|
| 235 | + | DRUGS; OR27 |
---|
| 236 | + | 1122 |
---|
| 237 | + | -6- (h) CREATE ANY ADDITIONAL REQUIREMENTS OR RESTRICTIONS ON1 |
---|
| 238 | + | A 340B COVERED ENTITY OR CONTRACT PHARMACY .2 |
---|
| 239 | + | (2) U |
---|
| 240 | + | NLESS A CLAIM IS FOR PAYMENT, DIRECTLY OR INDIRECTLY,3 |
---|
| 241 | + | BY THE MEDICAID PROGRAM , A PHARMACY BENEFIT MANAGER OR ANY4 |
---|
| 242 | + | OTHER THIRD PARTY THAT REIMBURSES A 340B COVERED ENTITY |
---|
| 243 | + | OR5 |
---|
| 244 | + | CONTRACT PHARMACY FOR 340B DRUGS SHALL NOT REQUIRE A CLAIM FOR6 |
---|
| 245 | + | A 340B DRUG TO INCLUDE:7 |
---|
| 246 | + | (a) A |
---|
| 247 | + | MODIFIER TO INDICATE THAT THE DRUG IS A 340B DRUG; OR8 |
---|
177 | | - | SSESS ANY FEE, CHARGE BACK, OR OTHER ADJUSTMENT |
---|
178 | | - | AGAINST THE |
---|
179 | | - | 340B COVERED ENTITY OR CONTRACT PHARMACY ON THE |
---|
180 | | - | BASIS THAT THE |
---|
181 | | - | 340B COVERED ENTITY OR CONTRACT PHARMACY |
---|
182 | | - | PARTICIPATES IN THE |
---|
183 | | - | 340B PROGRAM; |
---|
184 | | - | PAGE 4-HOUSE BILL 22-1122 (c) RESTRICT ACCESS TO THE THIRD PARTY'S PHARMACY NETWORK |
---|
185 | | - | FOR ANY |
---|
186 | | - | 340B COVERED ENTITY OR CONTRACT PHARMACY ON THE BASIS |
---|
187 | | - | THAT THE |
---|
188 | | - | 340B COVERED ENTITY OR CONTRACT PHARMACY PARTICIPATES |
---|
189 | | - | IN THE |
---|
190 | | - | 340B PROGRAM; |
---|
191 | | - | (d) R |
---|
192 | | - | EQUIRE THE 340B COVERED ENTITY OR CONTRACT PHARMACY |
---|
193 | | - | TO ENTER INTO A CONTRACT WITH A SPECIFIC PHARMACY OR HEALTH |
---|
194 | | - | COVERAGE PLAN TO PARTICIPATE IN THE THIRD PARTY |
---|
195 | | - | 'S PHARMACY |
---|
196 | | - | NETWORK |
---|
197 | | - | ; |
---|
198 | | - | (e) C |
---|
199 | | - | REATE A RESTRICTION OR AN ADDITIONAL CHARGE ON A |
---|
200 | | - | PATIENT WHO CHOOSES TO RECEIVE DRUGS FROM A |
---|
201 | | - | 340B COVERED ENTITY |
---|
202 | | - | OR CONTRACT PHARMACY |
---|
203 | | - | ; |
---|
204 | | - | (f) R |
---|
205 | | - | ESTRICT THE METHODS BY WHICH A 340B COVERED ENTITY OR |
---|
206 | | - | CONTRACT PHARMACY MAY DISPENSE OR DELIVER |
---|
207 | | - | 340B DRUGS; |
---|
208 | | - | (g) R |
---|
209 | | - | EFUSE TO PROVIDE REIMBURSEMENT OR COVERAGE FOR 340B |
---|
210 | | - | DRUGS; OR |
---|
211 | | - | (h) CREATE ANY ADDITIONAL REQUIREMENTS OR RESTRICTIONS ON |
---|
212 | | - | A |
---|
213 | | - | 340B COVERED ENTITY OR CONTRACT PHARMACY . |
---|
214 | | - | (2) U |
---|
215 | | - | NLESS A CLAIM IS FOR PAYMENT, DIRECTLY OR INDIRECTLY, BY |
---|
216 | | - | THE MEDICAID PROGRAM |
---|
217 | | - | , A PHARMACY BENEFIT MANAGER OR ANY OTHER |
---|
218 | | - | THIRD PARTY THAT REIMBURSES A |
---|
219 | | - | 340B COVERED ENTITY OR CONTRACT |
---|
220 | | - | PHARMACY FOR |
---|
221 | | - | 340B DRUGS SHALL NOT REQUIRE A CLAIM FOR A 340B |
---|
222 | | - | DRUG TO INCLUDE: |
---|
223 | | - | (a) A |
---|
224 | | - | MODIFIER TO INDICATE THAT THE DRUG IS A 340B DRUG; OR |
---|
225 | | - | (b) ANY OTHER METHOD OF IDENTIFYING THE CLAIM FOR A 340B |
---|
226 | | - | DRUG. |
---|
| 249 | + | NY OTHER METHOD OF IDENTIFYING THE CLAIM FOR A 340B9 |
---|
| 250 | + | DRUG.10 |
---|
228 | | - | ITH RESPECT TO A PATIENT ELIGIBLE TO RECEIVE 340B DRUGS, |
---|
229 | | - | A PHARMACY BENEFIT MANAGER OR ANY OTHER THIRD PARTY THAT MAKES |
---|
230 | | - | PAYMENT FOR THE DRUGS SHALL NOT DISCRIMINATE AGAINST A |
---|
231 | | - | 340B |
---|
232 | | - | COVERED ENTITY OR CONTRACT PHARMACY IN A MANNER THAT PREVENTS |
---|
233 | | - | OR INTERFERES WITH THE PATIENT |
---|
234 | | - | 'S CHOICE TO RECEIVE THE DRUGS FROM |
---|
235 | | - | THE |
---|
236 | | - | 340B COVERED ENTITY OR CONTRACT PHARMACY . |
---|
237 | | - | PAGE 5-HOUSE BILL 22-1122 10-16-1506. Enforcement - rules. (1) A THIRD PARTY THAT |
---|
238 | | - | VIOLATES THIS PART |
---|
239 | | - | 15 ENGAGES IN AN UNFAIR OR DECEPTIVE ACT OR |
---|
240 | | - | PRACTICE IN THE BUSINESS OF INSURANCE UNDER SECTION |
---|
241 | | - | 10-3-1104 (1)(tt), |
---|
242 | | - | AND THE ACT OF THE THIRD PARTY THAT VIOLATES THIS PART 15 IS VOID AND |
---|
243 | | - | UNENFORCEABLE |
---|
244 | | - | . |
---|
| 252 | + | ITH RESPECT TO A PATIENT ELIGIBLE TO RECEIVE 340B11 |
---|
| 253 | + | DRUGS, A PHARMACY BENEFIT MANAGER OR ANY OTHER THIRD PARTY12 |
---|
| 254 | + | THAT MAKES PAYMENT FOR THE DRUGS SHALL NOT DISCRIMINATE13 |
---|
| 255 | + | AGAINST A 340B COVERED ENTITY |
---|
| 256 | + | OR CONTRACT PHARMACY IN A MANNER14 |
---|
| 257 | + | THAT PREVENTS OR INTERFERES WITH THE PATIENT 'S CHOICE TO RECEIVE15 |
---|
| 258 | + | THE DRUGS FROM THE 340B COVERED ENTITY OR CONTRACT PHARMACY. 16 |
---|
| 259 | + | 10-16-1506. Enforcement - rules. (1) A |
---|
| 260 | + | THIRD PARTY THAT17 |
---|
| 261 | + | VIOLATES THIS PART 15 ENGAGES IN AN UNFAIR OR DECEPTIVE ACT OR18 |
---|
| 262 | + | PRACTICE IN THE BUSINESS OF INSURANCE UNDER SECTION 10-3-110419 |
---|
| 263 | + | (1)(tt), |
---|
| 264 | + | AND THE ACT OF THE THIRD PARTY THAT VIOLATES THIS PART 15 IS20 |
---|
| 265 | + | VOID AND UNENFORCEABLE .21 |
---|
246 | | - | HE COMMISSIONER MAY ADOPT RULES AS NECESSARY TO |
---|
247 | | - | IMPLEMENT THIS PART |
---|
248 | | - | 15. |
---|
249 | | - | SECTION 2. In Colorado Revised Statutes, 10-3-1104, add (1)(tt) |
---|
250 | | - | as follows: |
---|
251 | | - | 10-3-1104. Unfair methods of competition - unfair or deceptive |
---|
252 | | - | practices. (1) The following are defined as unfair methods of competition |
---|
253 | | - | and unfair or deceptive acts or practices in the business of insurance: |
---|
| 267 | + | HE COMMISSIONER MAY ADOPT RULES AS NECESSARY TO22 |
---|
| 268 | + | IMPLEMENT THIS PART 15. 23 |
---|
| 269 | + | SECTION 2. |
---|
| 270 | + | In Colorado Revised Statutes, 10-3-1104, add24 |
---|
| 271 | + | (1)(tt) as follows:25 |
---|
| 272 | + | 10-3-1104. Unfair methods of competition - unfair or deceptive26 |
---|
| 273 | + | practices. (1) The following are defined as unfair methods of27 |
---|
| 274 | + | 1122 |
---|
| 275 | + | -7- competition and unfair or deceptive acts or practices in the business of1 |
---|
| 276 | + | insurance:2 |
---|
255 | | - | VIOLATION OF PART 15 OF ARTICLE 16 OF THIS TITLE 10. |
---|
256 | | - | SECTION 3. Appropriation. For the 2022-23 state fiscal year, |
---|
257 | | - | $17,109 is appropriated to the department of regulatory agencies for use by |
---|
258 | | - | the division of insurance. This appropriation is from the division of |
---|
259 | | - | insurance cash fund created in section 10-1-103 (3), C.R.S., and is based on |
---|
260 | | - | an assumption that the division will require an additional 0.3 FTE. To |
---|
261 | | - | implement this act, the division may use this appropriation for personal |
---|
262 | | - | services. |
---|
263 | | - | SECTION 4. Act subject to petition - effective date. This act |
---|
264 | | - | takes effect at 12:01 a.m. on the day following the expiration of the |
---|
265 | | - | ninety-day period after final adjournment of the general assembly; except |
---|
266 | | - | that, if a referendum petition is filed pursuant to section 1 (3) of article V |
---|
267 | | - | of the state constitution against this act or an item, section, or part of this act |
---|
268 | | - | within such period, then the act, item, section, or part will not take effect |
---|
269 | | - | unless approved by the people at the general election to be held in |
---|
270 | | - | PAGE 6-HOUSE BILL 22-1122 November 2022 and, in such case, will take effect on the date of the official |
---|
271 | | - | declaration of the vote thereon by the governor. |
---|
272 | | - | ____________________________ ____________________________ |
---|
273 | | - | Alec Garnett Steve Fenberg |
---|
274 | | - | SPEAKER OF THE HOUSE PRESIDENT OF |
---|
275 | | - | OF REPRESENTATIVES THE SENATE |
---|
276 | | - | ____________________________ ____________________________ |
---|
277 | | - | Robin Jones Cindi L. Markwell |
---|
278 | | - | CHIEF CLERK OF THE HOUSE SECRETARY OF |
---|
279 | | - | OF REPRESENTATIVES THE SENATE |
---|
280 | | - | APPROVED________________________________________ |
---|
281 | | - | (Date and Time) |
---|
282 | | - | _________________________________________ |
---|
283 | | - | Jared S. Polis |
---|
284 | | - | GOVERNOR OF THE STATE OF COLORADO |
---|
285 | | - | PAGE 7-HOUSE BILL 22-1122 |
---|
| 278 | + | VIOLATION OF PART 15 OF ARTICLE 16 OF THIS TITLE 10.3 |
---|
| 279 | + | SECTION 3. Appropriation. For the 2022-23 state fiscal year,4 |
---|
| 280 | + | $17,109 is appropriated to the department of regulatory agencies for use5 |
---|
| 281 | + | by the division of insurance. This appropriation is from the division of6 |
---|
| 282 | + | insurance cash fund created in section 10-1-103 (3), C.R.S., and is based7 |
---|
| 283 | + | on an assumption that the division will require an additional 0.3 FTE. To8 |
---|
| 284 | + | implement this act, the division may use this appropriation for personal9 |
---|
| 285 | + | services.10 |
---|
| 286 | + | SECTION 4. Act subject to petition - effective date. This act11 |
---|
| 287 | + | takes effect at 12:01 a.m. on the day following the expiration of the12 |
---|
| 288 | + | ninety-day period after final adjournment of the general assembly; except13 |
---|
| 289 | + | that, if a referendum petition is filed pursuant to section 1 (3) of article V14 |
---|
| 290 | + | of the state constitution against this act or an item, section, or part of this15 |
---|
| 291 | + | act within such period, then the act, item, section, or part will not take16 |
---|
| 292 | + | effect unless approved by the people at the general election to be held in17 |
---|
| 293 | + | November 2022 and, in such case, will take effect on the date of the18 |
---|
| 294 | + | official declaration of the vote thereon by the governor.19 |
---|
| 295 | + | 1122 |
---|
| 296 | + | -8- |
---|